Filing Details

Accession Number:
0001225208-20-010009
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-28 18:43:57
Reporting Period:
2020-07-28
Accepted Time:
2020-07-28 18:43:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1745936 Ashley Mcevoy One Johnson & Johnson Plaza
New Brunswick NJ 08933
Evp, Ww Chair, Medical Devices No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-28 29,000 $147.47 21,682 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,451 Indirect By 401k
Common Stock 300 Indirect By ESOP
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $147.33 to $147.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2020).
  3. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2020).